Amneal Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AMRX and other ETFs, options, and stocks.About AMRX
Amneal Pharmaceuticals, Inc. is a medicine company, which engages in the provision of pharmaceuticals. Its product portfolio includes generics, specialty, biosciences, and product catalog.
CEOChintu Patel
CEOChintu Patel
Employees8,300
Employees8,300
HeadquartersBridgewater, New Jersey
HeadquartersBridgewater, New Jersey
Founded2002
Founded2002
Employees8,300
Employees8,300
AMRX Key Statistics
Market cap3.02B
Market cap3.02B
Price-Earnings ratio1.52K
Price-Earnings ratio1.52K
Dividend yield—
Dividend yield—
Average volume1.72M
Average volume1.72M
High today$9.81
High today$9.81
Low today$9.57
Low today$9.57
Open price$9.72
Open price$9.72
Volume2.26M
Volume2.26M
52 Week high$10.34
52 Week high$10.34
52 Week low$6.69
52 Week low$6.69
AMRX News
TipRanks 2d
Amneal Pharmaceuticals price target raised to $14 from $12 at JPMorganJPMorgan analyst Chris Schott raised the firm’s price target on Amneal Pharmaceuticals (AMRX) to $14 from $12 and keeps an Overweight rating on the shares. The...
Simply Wall St 4d
What Amneal Pharmaceuticals's FDA Exclusivity Win for Risperidone Injectable Means For ShareholdersAmneal Pharmaceuticals recently received U.S. FDA approval for two products: sodium oxybate oral solution for narcolepsy and risperidone extended-release inject...
Seeking Alpha 6d
Amneal wins FDA nod for generic targeting Jazz Pharma’s XyremAmneal Pharmaceuticals (NASDAQ:AMRX) announced on Thursday that the U.S. Food and Drug Administration (FDA) approved its generic product targeting Jazz Pharmace...
People also own
Based on the portfolios of people who own AMRX. This list is generated using Robinhood data, and it’s not a recommendation.